21569551|t|The relation of high fat diet, metabolic disturbances and brain oxidative dysfunction: modulation by hydroxy citric acid.
21569551|a|AIMS: This study aimed to examine the effect of high fat diet (HFD) to modulate brain dysfunction, and understand the linkages between obesity, metabolic disturbances and the brain oxidative stress (BOS) dysfunction and modulation with hydroxyl citric acid of G. Cambogia. METHODS: Rats were divided into 3 groups; 1st control, maintained on standard normal rat chow diet, 2nd HFD, maintained on high fat diet along 12 week and 3rd HFD+G, administered G. Cambogia for 4 weeks and each group include 8 rats. Blood, brain and abdominal fat were collected for biochemical measurements. RESULTS: HFD group showed significant increase in energy intake, final BW and BW gain. Also significant increase in weight of abdominal fat in HFD group. HFD induce metabolic disturbance through increasing the lipid profile (LDL, TG, TC), gammaGT and alpha-amylase activity, uric acid level and hyperglycemia, while decreasing creatine kinase (CK) activity.These changes associated with lowering in brain nitric oxide (NO) level and rising in serum butyrylcholinesterase (BChE), brain catalase activity and MDA levels as oxidative stress markers. These alterations improved by G. Cambogia that decrease BOS and increased NO level. CONCLUSIONS: Rats fed HFD showed, metabolic disturbances produce hyperglycemia, hypertriglyceridemia, hypercholesterolemia and increased LDL associated with increased BOS. Involvement of BuChE, NO and oxidative stress associated with metabolic disturbances in the pathophysiological progression in brain, suggesting association between obesity, metabolic disorders and brain alteration while, using G. Cambogia, ameliorate the damaging effects of the HFD via lowering feed intake and BOS.
21569551	31	53	metabolic disturbances	Disease	MESH:D024821
21569551	58	85	brain oxidative dysfunction	Disease	MESH:D001927
21569551	101	120	hydroxy citric acid	Chemical	MESH:C007999
21569551	202	219	brain dysfunction	Disease	MESH:D001927
21569551	257	264	obesity	Disease	MESH:D009765
21569551	266	288	metabolic disturbances	Disease	MESH:D024821
21569551	297	319	brain oxidative stress	Disease	MESH:D001927
21569551	321	337	BOS) dysfunction	Disease	MESH:D001927
21569551	358	378	hydroxyl citric acid	Chemical	-
21569551	382	393	G. Cambogia	Chemical	-
21569551	404	408	Rats	Species	10116
21569551	480	483	rat	Species	10116
21569551	574	585	G. Cambogia	Chemical	-
21569551	623	627	rats	Species	10116
21569551	870	891	metabolic disturbance	Disease	MESH:D024821
21569551	915	920	lipid	Chemical	MESH:D008055
21569551	930	933	LDL	Chemical	-
21569551	935	937	TG	Chemical	MESH:D013866
21569551	939	941	TC	Chemical	MESH:D013667
21569551	980	989	uric acid	Chemical	MESH:D014527
21569551	1000	1013	hyperglycemia	Disease	MESH:D006943
21569551	1110	1122	nitric oxide	Chemical	MESH:D009569
21569551	1154	1175	butyrylcholinesterase	Gene	65036
21569551	1177	1181	BChE	Gene	65036
21569551	1190	1198	catalase	Gene	24248
21569551	1212	1215	MDA	Chemical	MESH:D015104
21569551	1282	1293	G. Cambogia	Chemical	-
21569551	1308	1311	BOS	Disease	MESH:D001927
21569551	1349	1353	Rats	Species	10116
21569551	1370	1392	metabolic disturbances	Disease	MESH:D024821
21569551	1401	1414	hyperglycemia	Disease	MESH:D006943
21569551	1416	1436	hypertriglyceridemia	Disease	MESH:D015228
21569551	1438	1458	hypercholesterolemia	Disease	MESH:D006937
21569551	1473	1476	LDL	Chemical	-
21569551	1503	1506	BOS	Disease	MESH:D001927
21569551	1570	1592	metabolic disturbances	Disease	MESH:D024821
21569551	1672	1679	obesity	Disease	MESH:D009765
21569551	1681	1700	metabolic disorders	Disease	MESH:D008659
21569551	1711	1721	alteration	Disease	MESH:D004408
21569551	1735	1746	G. Cambogia	Chemical	-
21569551	1820	1823	BOS	Disease	MESH:D001927
21569551	Positive_Correlation	MESH:D014527	MESH:D024821
21569551	Positive_Correlation	MESH:D013866	MESH:D024821
21569551	Association	MESH:C007999	MESH:D001927
21569551	Positive_Correlation	MESH:D013667	MESH:D024821

